Clinical trial for Alzheimer's drug in Tampa
According to a study published online this week by Proceedings of the National Academy of Sciences, drugs used to keep diabetes under control may also shield memory-forming nerve connections from harmful Alzheimer’s related proteins.
The discovery that insulin may slow or prevent Alzheimer's-related memory loss fuels existing theories that the disease may be caused by a third type of diabetes.
Currently, more than 5 million Americans suffer from Alzheimer's, which is characterized by an excessive amount of proteins that build up in plaque deposits and cause damage to nerve cells and inflammation in the brain.
Research trials for a drug to cure the disease are ongoing everywhere, including in Tampa.
Dr. Susan Steen is president of Axiom Clinical Research of Florida, which does clinical trials for neurological illness. For more information about the Alzheimer’s Clinical trial she’s helping supervise, call 1-888-770-6366, or go to the website.comments powered by Disqus